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Background: COPD is an umbrella term to describe chronic lung diseases that cause limitations 
in lung airflow, including emphysema and chronic bronchitis. The prevalence of depression 
and anxiety in people with COPD is high, although these comorbidities are often undiagnosed, 
untreated, or undertreated. There is a need to identify efficacious treatments for depression and 
anxiety in people with COPD. Cognitive behavior therapy (CBT) for the treatment of anxiety 
and depression has a strong evidence base. There has been some success delivering this treat-
ment over the telephone in limited studies. The aim of this study is to evaluate the efficacy of 
both telephone-administered CBT and befriending on outcomes for patients with diagnosed 
COPD who have at least mild levels of depression and/or anxiety.
Methods: The protocol described in this paper is of a pragmatic randomized controlled trial 
comparing eight sessions of telephone CBT to an active social control, referred to as befriending. 
Primary outcome measures will include depression and anxiety symptoms, and secondary outcome 
measures will include quality of life, self-efficacy, and COPD symptom severity. Participants’ 
satisfaction with the intervention and therapeutic alliance will also be assessed. Measures will be 
taken pre- and postdelivery of the intervention and again at 8 weeks following the intervention.
Conclusion: People with COPD often have limitations to their mobility because of their breath-
lessness. They are often already attending many medical appointments and could be reluctant 
to attend for face-to-face psychological treatment. The results of this study should identify the 
relative efficacy of CBT delivered over the telephone to this population, which, if successful, 
may be a cost-effective and more palatable alternative to face-to-face treatment of depression 
or anxiety for this population.
Keywords: chronic obstructive pulmonary disease (COPD), depression, anxiety, telephone, 
cognitive behavior therapy (CBT), befriending
Background
COPD is a long-term lung disease characterized by airflow obstruction and shortness 
of breath, which progressively limit activities of daily living. In addition to shortness of 
breath, other symptoms of COPD include wheezing, coughing, mucus, fatigue, cyanosis, 
and increased susceptibility to chest infections. An estimated 2 million Australians are 
affected by COPD,1 with 1.2 million having moderate-to-severe COPD.
COPD has multiple comorbidities, and two of the most common and least-treated 
comorbidities are depression and anxiety.2 There has been no consensus on the preva-
lence of depression and anxiety in people with COPD, due in part to the variation in 
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measurement tools and the severity of illness in different 
studies. However, it has been estimated that one in four 
people with COPD experience clinically significant depres-
sive symptoms, and up to 40% of people with COPD suffer 
from clinical anxiety.3
The exact cause of depression and anxiety in people with 
COPD is unknown; however, some of the variables that have 
been implicated include physical disability, long-term oxygen 
therapy, low body mass index, severe dyspnea, percentage 
of predicted forced expiratory volume in 1 second (FEV
1
), 
poor quality of life, presence of comorbidities, living alone, 
female sex, current smoking, and low social class status.2
Although depression and anxiety are common in patients 
with COPD, they are often undetected, undertreated, or even 
untreated.2 This can lead to increased mortality risk, reduced 
compliance with management plans, impaired health-
related quality of life, slower recovery from exacerbations, 
and increased health-care utilization and costs.2–4
Regarding the treatment options of depression and 
anxiety in patients with COPD, researchers have suggested 
promoting nonpharmacological interventions as the first-
line therapy. Of those, cognitive behavior therapy (CBT) 
has been offered by trained CBT therapists or other health 
professionals, such as community nurses.5–7 CBT is a type 
of psychological therapy or counseling technique that helps a 
person change unhelpful or unhealthy thinking, their thoughts 
or cognitions, and also their actions or behaviors. Previous 
systematic reviews have reported that there is some support 
for using this therapy to improve the condition of people 
with COPD, reducing their anxiety and depression levels;5,8 
however, there is debate about the evidence that is largely 
derived from either small, randomized controlled trials or 
uncontrolled or nonrandomized studies.5
People with COPD can often be disabled and have physi-
cal limitations, which may impact on their ability to travel 
to various medical appointments. Physical mobility restric-
tions and issues with transport have been reported as factors 
preventing people from participating in intervention trials.9 
It has been reported that approximately 75% of depressed 
primary care patients report barriers that make it difficult 
for them to attend regular psychotherapy sessions.10 These 
barriers include lack of accessible services, transportation 
services, and cost.
Telephone-administered CBT allows people to receive 
counseling therapy in their own homes. It has lower attrition 
rates compared to face-to-face CBT10 and has been found to 
be as effective in reducing depression and anxiety as face-
to-face CBT.10,11 Telephone-administered CBT may provide 
those people with COPD who have physical limitations that 
prevent them from attending medical appointments at a 
hospital or medical center, with the opportunity to receive 
counseling therapy.
Study aims and objectives
Aim
The aim of this trial is to evaluate the efficacy of telephone-
administered CBT compared with an active social control – 
befriending – on outcomes for patients with diagnosed 
COPD who have at least mild levels of depression and/or 
anxiety.
Objectives
The study objectives are to:
1) Investigate changes to levels of depression and anxiety 
in participants before and after the telephone intervention 
and at follow-up and compare these between the groups 
receiving the CBT intervention with those receiving 
befriending;
2) Investigate changes to secondary outcome measures 
such as self-efficacy, quality of life, and COPD symptom 
severity; and
3) Evaluate therapeutic alliance and participants’ level of 
satisfaction with the intervention they receive.
Methods
Study design
This study is a pragmatic randomized controlled trial.12 
It includes a telephone screen (conducted by the researchers 
using standardized screening scales) for identifying eligible 
participants, baseline assessment for assessing enrolled par-
ticipants’ health and well-being, randomized allocation of the 
participants to the intervention (CBT) or control (befriending) 
group, initial session to build rapport, 8 weekly telephone 
interventions of either CBT or befriending, a postinterven-
tion follow-up assessment, and another follow-up assessment 
8 weeks after the intervention (Figure 1). The study is blind 
to the researchers undertaking the baseline and follow-up 
assessments, and the data analysis. Owing to the nature of 
the intervention and control conditions, the therapists and 
volunteers delivering the interventions and the participants 
are not able to be blind to the conditions.
Ethical considerations
Ethical approvals for the trial have been obtained 
from Melbourne Health, Alfred Health, Austin Health, 
Barwon Health, Eastern Health, and Bendigo Health. 
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The trial is registered with the ANZ trial register 
(ACTRN12612000254897).
Study procedures
Power and sample size
Using the effect sizes published in a systematic review of the 
impact of CBT on depression and anxiety that were measured 
by different instruments such as Symptom Checklist-90-
Revised (SCR-90-R), Geriatric Depression Scale (GDS), 
Beck Depression Inventory (BDI), and Beck Anxiety Inven-
tory (BAI) in the included studies,8 it is expected that there 
will be standardized mean difference effect size between 
CBT and usual care of 0.5–0.6 on this outcome (calculated 
using the METAN procedure from Stata 11 using published 
effect sizes for depression and anxiety). It is reasonable to 
assume that telephone CBT will provide a similar effect size 
to that found in studies of face-to-face CBT. For a study 
with 80% power and alpha error probability of 0.05, we 
will require at least 65 patients per group. Assuming loss to 
follow-up of 5%–10%, we will aim to have 70 patients in 
each group. On a conservative estimate based on prevalence 
figures published in the literature and our current study, it 
is expected that 40% of patients referred to the outpatient 
clinics will have at least mild depression and/or anxiety; so 
350 patients may need to be screened to provide the sample 
size of 140 altogether. In a previous study, we recruited 103 
people with COPD attending 22 pulmonary rehabilitation 
(PR) clinics into the study over a 12-month period;13 so we 
estimate that 30 months should be sufficient time to recruit 
the 140 clients required for this study.
Participant inclusion criteria
Eligible participants will be patients with a diagnosis of 
COPD together with the following characteristics: 1) liv-
ing in the community; 2) aged 45 years or older; 3) hav-
ing a telephone and being able to hear over the phone; 
Figure 1 Study design.
Abbreviation: CBt, cognitive behavioral therapy.
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4) understanding and speaking English; 5) having been 
on a stable dose for at least 3 months if on psychotropic 
medication; and 6) scoring 8 or more on the Hospital Anxiety 
and Depression Scale (HADS) or 10 or more on the Patient 
Health Questionnaire-9 (PHQ-9). Because of its brevity, 
HADS will be used during the telephone screening to deter-
mine eligibility of the patients.
Notably, where possible, diagnosis of COPD will be con-
firmed by participants’ general physicians. For participants 
who are self-referred from the Newsletters or Website, their 
diagnosis will be assumed from self-report, COPD Assess-
ment Test (CAT) result, and lung function tests.
recruitment and baseline assessment
Participants will be recruited from the outpatient clinics of 
respiratory departments of tertiary hospitals in Victoria, from 
Pulmonary Rehabilitation Programs across the Melbourne 
metropolitan area, and from advertisements on patient sup-
port group websites. In the first two recruitment sources, 
patients with a diagnosis of COPD will be identified and then 
referred to the researchers of this study by a member of the 
team providing respiratory health care. The researchers will 
then assess each patient’s eligibility for this study through 
conducting a telephone screening.
For all participants recruited, the researchers will under-
take the formal consent process during the introduction 
session. Information and consent forms will be posted to 
eligible participants, then written formal consent will be 
obtained at the participant’s home or a public place where 
the introduction session is conducted. If the introduction 
session is to be conducted over the phone, participants 
will be instructed to mail their consent forms back to the 
researchers, and the intervention will not commence until 
consent forms are received. The researchers will fully 
explain the nature of the study to the participants, includ-
ing their right to withdraw consent at any time. Once the 
participant’s informed consent is obtained, the baseline 
assessment will be obtained by using the assessment tools 
outlined in Table 1.
randomization
Following the baseline assessment, participants will be 
randomly allocated to the CBT or befriending condition. 
Randomization will be managed by a trial statistician who 
is not directly involved in the project. A computer-generated 
random sequence available only to the trial statistician will 
be used to produce randomized allocation slips. The latter 
will use a randomized permuted block design with block 
size of 4, 6, or 8 in order to maintain approximately balanced 
randomization throughout the trial. Participants will then be 
contacted by their telephone support person, and an introduc-
tory session will be arranged either at the participant’s home, 
in a public space such as a coffee shop (if the participant 
refuses a home visit), or over the phone (if the participant 
lives in remote area), in order to reinforce the procedure, 
introduce the telephone support person, explain the project, 
and establish rapport.
telephone CBt and befriending interventions
The 8 weekly telephone interventions/sessions of the CBT 
and befriending will then commence. Up to ten therapists 
(providing CBT sessions) and up to ten volunteers (providing 
befriending sessions) will participate in this study consider-
ing the participant flow and availability of therapists and 
volunteers. Variability between providers will be controlled 
through training and quality monitoring by the chief investi-
gators (SB and CD) of this study. Details about the telephone 
interventions are described in the following sections.
Cognitive behavior therapy
The treatment program will include behavioral strategies 
such as behavioral activation, activity scheduling, relaxation 
training, exposure hierarchies, and social skills training, as 
well as cognitive strategies, such as cognitive restructuring, 
Table 1 Outcome measures used at different assessment points in the study
Domains Primary or secondary measure Instrument T1a T2b T3c
Health and well-being Depression (primary) Patient Health Questionnaire-9   
Anxiety (primary) Beck Anxiety Inventory   
Health-related quality of life (secondary) the COPD Assessment test   
Self-efficacy (secondary) General Self-Efficacy Scale   
Intervention response Participant satisfaction Client Satisfaction Questionnaire 
therapeutic alliance Working Alliance Inventory-Short 
Demographic and health-related Information Stable demographic factors Interview 
Variable demographic factors and health factors Interview   
Note: aBaseline assessment, bpostintervention assessment, cfollow-up assessment 8 weeks after the CBt/befriending intervention.
Abbreviation: CBt, cognitive behavior therapy.
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structured problem solving, and behavioral experiments. 
Interventions will be delivered from a treatment protocol 
but be flexibly tailored to the conceptualization of the 
individual’s presenting problem. Following an initial session 
getting to know one another, eight sessions of telephone-
administered CBT are offered. Specific topics of the eight 
therapy sessions will be as follows: session 1 “depression and 
activity tracking”; session 2 “activity scheduling”; session 3 
“relaxation skills”; session 4 “cognitive restructuring”; 
session 5 “problem solving”; session 6 “sleep management”; 
session 7 “review and practice coping skills”; and session 8 
“maintaining gains and goodbye”. A manual (available from 
authors) that introduces these sessions and the procedures of 
conducting the sessions has been developed based on previ-
ous academic clinical trials that demonstrate efficacy of the 
procedures for older adults with anxiety14–16 and younger 
patients with depression.17,18
The telephone calls will occur weekly, at a time con-
venient to both the therapist and participant and will be 
of approximately 30 minutes in duration. The therapist 
delivering the intervention will be a registered or provision-
ally registered psychologist experienced in the delivery of 
telephone CBT and with knowledge of COPD education. 
Integrity of interventions and consistency of treatment across 
sites as indicated in the manual will be maintained with the 
use of a treatment protocol, therapist competency audits, 
training workshops for therapists, and ongoing supervision 
by a clinical psychologist. The CBT telephone calls will be 
audio recorded to assist with such monitoring.
Active social control: befriending
The control group will be provided with a course of 
befriending. Befriending will focus on neutral topics and will 
avoid discussion of symptoms or difficulties in client’s lives. 
In previous studies,19 befriending has been used to control for 
the factors of time and therapeutic alliance that could arise 
as a result of CBT in a randomized controlled trial of CBT 
for treatment-resistant psychosis, but it has not been used 
for participants with COPD. Previous studies showed that 
befriending was effective in reducing symptoms in people 
with psychosis but less so than CBT at 1-year follow-up. 
Such studies suggested that spending time talking to and then 
developing a relationship with a person may be seen to be 
as beneficial in the short-term to the person as the treatment 
from the CBT.20 A key characteristic of befriending is that it 
can be administered by individuals without psychological or 
medical training; thus it is potentially cheaper to provide.
Befriending involves a series of conversations with a 
person similar to those that one would have with a social 
acquaintance, involving discussion of neutral, everyday 
topics and events in a friendly manner. There is no problem 
solving or exploration of emotions in befriending.
In this study, the befriending condition will consist 
of one introductory session, followed by eight scheduled 
weekly telephone calls. Each telephone call will last 
approximately 30 minutes and be audio recorded to enable 
monitoring. The befrienders (volunteers) will be provided 
with training and a manual on befriending (adapted from 
Bendall et al’s work19 and available from authors). The 
manual includes guidelines around focusing on neutral 
topics, developing a therapeutic relationship, introducing 
and orienting a client to befriending, what to do if the cli-
ent deviates from neutral topics, and how to manage client 
distress, and confidentiality and safety issues for both the 
befriender and the client.
Follow-up assessments
Following the telephone interventions, a postintervention 
assessment will occur for each participant. Besides the same 
assessment tools as those used in the baseline assessment, 
two additional assessment tools will be used to assess par-
ticipants’ response to the interventions (Table 1). In addition, 
8 weeks after the interventions, the researchers will conduct 
a second follow-up assessment by using the measurement 
tools presented in Table 1.
Outcomes and measures
A range of outcome measures will be used at different 
assessment points. These measures will assess emotional 
well-being (depression, anxiety, and self-efficacy), physical 
well-being relating to living with COPD (health status), par-
ticipant satisfaction with the intervention, and the therapeutic 
alliance. In addition, participants will be asked for basic 
demographic information and a self-rating of other health 
problems (Table 1).
Health and well-being outcome measures
Depression (primary outcome)
The PHQ-9 will be used to assess the level of depression 
in participants. It is a 9-item depression scale based on the 
Diagnostic and Statistical Manual of Mental Disorders, 
fourth edition (DSM-IV) criteria for depression and is 
designed as both a diagnostic instrument and a severity 
measure.21 It has good internal consistency and test–retest 
reliability and criterion validity.21 It is one of the instruments 
recommended for use in primary care in the UK to assess 
depression severity.22 Scores can range from 0 to 27, with 
higher scores reflecting more severe depression. The PHQ-9 
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has also demonstrated sensitivity to change over time and in 
response to treatment.23,24
Anxiety (primary outcome)
The BAI will be used to assess the level of anxiety in par-
ticipants.25 The BAI is a 21-item scale designed to measure 
the severity of anxiety in adults and adolescents. It has also 
been demonstrated to have sound psychometric properties 
when used in older adults.25
Health status (secondary outcome)
The COPD Assessment Test (CAT) is a validated instrument 
used to measure the impact of COPD.26 It is an eight-item 
self-report questionnaire that is simple and quick to complete 
and helps to assess the health status of people with COPD. It 
has been shown to be responsive to changes in health status 
resulting from exacerbations of the disease and treatment 
such as PR.27,28 Each item is scored from 0 to 5, representing 
the extent of the impact of that particular item, resulting in 
an overall score ranging from 0 to 40. Higher scores reflect 
greater impact of the disease, and changes of 2 points or more 
suggests a clinically significant difference.28
Self-efficacy (secondary outcome)
The General Self-Efficacy Scale is a 10-item scale designed 
to assess perceived self-efficacy. It is a measure of coping 
and adaptation and will be used to identify any impact of 
the intervention on these variables. Total scores can range 
from 10 to 40, with higher scores reflecting greater perceived 
self-efficacy.
Intervention response measures
Participant satisfaction
The acceptability of the intervention and participant sat-
isfaction will be assessed with the Client Satisfaction 
Questionnaire,29 which is an 8-item measure with good 
internal consistency widely used to assess patient satisfaction 
with services. Responses to each item are made on a four-
point Likert scale, with higher scores representing a greater 
level of satisfaction.
therapeutic alliance
Therapeutic alliance will be measured with the Working 
Alliance Inventory (WAI)-S. Therapeutic alliance is seen 
to be critical in the success of different forms of psycho-
therapy, with evidence demonstrating a relationship between 
therapeutic alliance and treatment outcome.30 Horwath and 
Greenberg31 developed the original WAI with both therapist 
and client versions, and this 36-item instrument was later 
shortened to 12 items by Tracey and Kokotovic.32 The WAI-S 
is a self-report questionnaire that measures therapeutic 
alliance and its relationship to the success or failure of an 
intervention. Three key aspects of the therapeutic alliance are 
assessed: 1) agreement on the tasks of therapy; 2) agreement 
on the goals of therapy; and 3) development of an affective 
bond, each of which is represented by a subscale comprising 
four items each. Items are scored on a 7-point Likert-type 
scale ranging from 0 (never) to 7 (always), with higher scores 
reflecting a more positive rating of working alliance. Both 
total scale scores and subscale scores have been demonstrated 
to be reliable.33
Demographics and health-related information
A range of demographics and health-related information 
will be collected from participants in order to describe the 
characteristics of the participant sample. These will include: 
1) age, sex, marital status, postcode, living arrangements, 
ethnicity, education level, occupation, and financial status; 
2) self-rated health, severity of medical conditions (measured 
by the Charlson Index34), date of diagnosis of COPD, par-
ticipation in PR program, and COPD severity (measured by 
average of three spirometer readings of FEV
1
).
Data analysis
Statistical analyses
Analysis will be on an intention-to-treat basis and reported 
in accordance with the revised CONSORT statement.35 The 
adequacy of the randomization procedures will be assessed 
by comparison of all baseline characteristics between the 
two study groups. The statistical test used to compare differ-
ences in mean depression and mean anxiety score between 
baseline and follow-up in the two groups will depend on the 
degree of skewness of the distribution of scores. If distribu-
tions are skewed, the nonparametric Mann–Whitney will 
be used, otherwise a simple two-sample t-test will be used. 
No adjustment will be made for multiple comparisons since 
the overall number of comparisons involving the outcome 
variable will be small.
Discussion
To our knowledge, this is the first randomized controlled 
trial that evaluates the efficacy of both telephone-adminis-
tered CBT and befriending on outcomes for patients with 
COPD who also have at least mild levels of depression and/
or anxiety. There has been evidence showing that com-
pared with face-to-face CBT, telephone CBT can achieve 
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comparative clinical effects11 or some better results, such as 
improving patients’ adherence to treatment.10,36 Therefore, in 
our study, we expect that the telephone CBT will reduce the 
levels of depression and anxiety and improve self-efficacy, 
quality of life, and COPD symptom severity in participants 
with COPD.
Telephone CBT is promising for patients with COPD and 
associated depression and anxiety because provision of face-
to-face CBT (at home, the clinic, or other locations) might 
be constrained by time, space, costs (such as travel costs), 
and patients’ abilities to access transport and care services.37 
If the current study proves the positive effects of telephone 
CBT, this model of intervention has a great potential to serve 
as prototype for practice of care professionals.
Methodological strengths of this study are as follows: 
first, a trial statistician conducting the computerized random-
ization procedure ensures chance allocation of participants 
to the intervention or control group; second, the choice of 
the primary and secondary outcomes and measurement tools 
is based on the best evidence available, enabling us to com-
prehensively evaluate the efficacy of telephone-administered 
CBT; third, by assessing the medium-term (at the 17-week 
follow-up) outcomes, we can identify differences in the 
effects of telephone-administered CBT and befriending that 
might emerge in the weeks following the completion of the 
interventions.
One limitation of this study was that we were not able to 
blind the therapists, volunteers, or participants, which might 
affect the intervention effects. For example, some participants 
might feel discouraged to be allocated to the control group; 
therefore, they would be less responsive to the befriending 
intervention. Another limitation might be related to the low 
participant representativeness by using the current recruit-
ment strategy. However, this is a recurring issue facing 
many randomized control trials. Finally, although in our 
study we examined medium-term (at the 17-week follow-up) 
intervention effects, it is unclear whether this is the optimum 
duration. Another longer-term follow-up is outside the fund-
ing of this study.
The findings of this study will add to the understanding 
of the role that telephone CBT may play in assisting patients 
with COPD who have significant levels of depression and 
anxiety, as well as suggest an appropriate model for trials of 
CBT in a wider range of population of this kind.
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